Yasuda Masayuki

Takahashi Nana, Shiga Yukihiro, Kiyota Naoki, Yasuda Masayuki, Takahashi Naoki, Sato Kota et al.

A vascular risk score (FSQ) identified POAG patients with vascular predisposition, showing increased optic nerve head blood flow pulsatility and reduced cold-induced flow, which may personalize glaucoma care.

Ninomiya Takahiro, Kiyota Naoki, Sharma Parmanand, Omodaka Kazuko, Himori Noriko, Yasuda Masayuki et al.

AI-assisted OCTA-measured FAZ changes correlated with inferocentral visual field defect progression in glaucoma. This suggests FAZ parameters could be valuable markers for monitoring disease worsening.

Kiyota Naoki, Shiga Yukihiro, Yasuda Masayuki, Aizawa Naoko, Omodaka Kazuko, Tsuda Satoru et al.

This pilot study found weaker optic nerve head vasoreactivity to oxygen, measured by laser speckle flowgraphy, was linked to faster visual field loss in glaucoma, suggesting a potential progression biomarker.

Kiyota Naoki, Shiga Yukihiro, Yasuda Masayuki, Aizawa Naoko, Omodaka Kazuko, Tsuda Satoru et al.

This study found sectoral optic nerve blood flow correlates with visual field defects and predicts progression, suggesting LSFG and systemic factors could help clinicians predict glaucoma severity and progression.

Kiyota Naoki, Shiga Yukihiro, Ichinohasama Kohei, Yasuda Masayuki, Aizawa Naoko, Omodaka Kazuko et al.

This study found ONH blood flow reacts differently than choroidal flow to IOP elevation, demonstrating ONH autoregulation. LSFG offers a reproducible way to assess dynamic ocular blood flow changes, aiding glaucoma research.

Tsuda Satoru, Yokoyama Yu, Chiba Naoki, Aizawa Naoko, Shiga Yukihiro, Yasuda Masayuki et al.

Tafluprost increased optic nerve blood flow and reduced IOP in myopic discs, suggesting a beneficial glaucoma treatment, especially for normal tension glaucoma.